Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir (Q95781752)
Jump to navigation
Jump to search
article by Weerawat Manosuthi et al published 1 January 2008 in Journal of Acquired Immune Deficiency Syndromes
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir |
article by Weerawat Manosuthi et al published 1 January 2008 in Journal of Acquired Immune Deficiency Syndromes |
Statements
Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir (English)
Weerawat Manosuthi
Somnuek Sungkanuparph
Wisit Prasithsirikul
Chatiya Athichathanabadi
Woraphot Tantisiriwat
Chureeratana Bowonwatanuwong
Nopphanath Chumpathat
Achara Chaovavanich